poisar

Stocks · News reference

Perspective Therapeutics Receives European Commission Orphan Designation For VMT-α-NET To Treat Gastroenteropancreatic Neuroendocrine Tumors

Jul 28, 2026, 10:42 AMBenzinga Newsdesk

The designation follows a positive opinion from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).Orphan medicinal product designation by the EC may provide certain development

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CATX
Source
benzinga
Observed
Jul 28, 2026, 10:42 AM
Checked
Jul 28, 2026, 10:42 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading